---
title: "Belotecan - Malignant Tumor Of Ovary"
sidebar: mydoc_sidebar
permalink: db12459-mesh-d010051-1.html
toc: false 
---


Path ID: `DB12459_MESH_D010051_1`
{% include image.html url="images/db12459-mesh-d010051-1.png" file="db12459-mesh-d010051-1.png" alt="db12459-mesh-d010051-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C116963 | belotecan | Drug |
| UniProt:P11387 | DNA topoisomerase 1 | Protein |
| GO:0003677 | DNA binding | MolecularActivity |
| GO:0006260 | DNA replication | BiologicalProcess |
| MESH:D010051 | Malignant tumor of ovary | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Belotecan | DECREASES ACTIVITY OF | Dna Topoisomerase 1 |
| Dna Topoisomerase 1 | POSITIVELY REGULATES | Dna Binding |
| Dna Binding | CORRELATED WITH | Dna Replication |
| Dna Replication | POSITIVELY CORRELATED WITH | Malignant Tumor Of Ovary |
|---------|-----------|---------|

Reference: 
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Belotecan-hydrochloride](https://pubchem.ncbi.nlm.nih.gov/compound/Belotecan-hydrochloride)
  - [https://en.wikipedia.org/wiki/Belotecan](https://en.wikipedia.org/wiki/Belotecan)
